20.550
−0,48%
2026-10-19
Fundamental Analysis
87 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +65.4% | +479.7% | 3 / 3 | +25.4% | -1.88 pp | +2.24 pp | +28.3% | 1.31 | 4.69 | 14.959 | +25,4% | 1.435 | +63,6% | 4.69 | 7.14 | −34,4% |
| Pts | 12 | 12 | 12 | 12 | 4 | 12 | 12 | 6 | 12 | |||||||
Valuation annotation:Price: 20.550 (close price on 2026-10-19)EPS (TTM): 4.385
Financial charts
1.Revenue & growth
VND bn14.959Q2/26
1.Revenue & growth
VND bn14.959Q2/26
2.Profit & growth
VND bn1.448Q2/26
3.Profit mix (Penman)
VND bn5.994Q2/26
4.Margins & cost structure
%16.1%Q2/26
5.Returns & cash cycle
% · days13.8%Q2/26
6.Earnings quality & cash
VND bn3.515Q2/26
7.Asset structure
VND bn54.680Q2/26
8.Funding & debt health
VND bn · times54.680Q2/26
9.Revenue backlog
VND bn873Q2/26
10.Valuation
times · %5,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.289Q2/26
Adjusted EPS growth, latest quarter
65.5%
Average adjusted EPS growth, 3 quarters
362%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26